Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe United Kingdom | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
  • Argentina | es
  • Canada | fr
  • Brazil | pt
  • Canada | en
  • Central America | es
  • Colombia | es
  • United States | en
  • Mexico | es
  • Venezuela | es
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Australia | en
  • Korea | ko
  • Bangladesh | en
  • Taiwan | zh
  • Singapore | en
  • Mainland China | zh
  • Philippines | en
  • Pakistan | en
  • Malaysia | en
  • Ireland | en
  • Greece | el
  • Hungary | hu
  • France | fr
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Germany | de
  • Finland | fi
  • Austria | de
  • Belgium | nl
  • Belgium | fr
  • Estonia | et
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Serbia | sr
  • United Kingdom | en
  • Switzerland | de
  • Switzerland | fr
  • Sweden | sv
  • Spain | es
  • Slovakia | sk
  • Russia | ru
  • Romania | ro
  • Portugal | pt
  • Poland | pl
  • Norway | no
  • Netherlands | nl
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Israel | he
  • Egypt | en
  • Turkey | tr
  • South Africa | en

Language & Country Selector for Mobile

language-selector-globe United Kingdom

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
  • Argentina | es
  • Ireland | en
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Israel | he
  • France | fr
  • Italy | it
  • Japan | ja
  • Australia | en
  • Latvia | lv
  • Lithuania | lt
  • Germany | de
  • Korea | ko
  • Finland | fi
  • Canada | fr
  • Austria | de
  • Bangladesh | en
  • Belgium | nl
  • Belgium | fr
  • Brazil | pt
  • Estonia | et
  • Bulgaria | bg
  • Canada | en
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Egypt | en
  • Serbia | sr
  • United States | en
  • United Kingdom | en
  • Turkey | tr
  • Taiwan | zh
  • Switzerland | de
  • Switzerland | fr
  • Sweden | sv
  • Spain | es
  • South Africa | en
  • Slovakia | sk
  • Singapore | en
  • Sandoz | en
  • Mainland China | zh
  • Russia | ru
  • Romania | ro
  • Portugal | pt
  • Poland | pl
  • Philippines | en
  • Pakistan | en
  • Novartis Foundation | en
  • Norway | no
  • Netherlands | nl
  • Mexico | es
  • Malaysia | en
  • Venezuela | es
    • About 
      • Novartis in the UK 
      • Partnerships 
        • Partners 
        • Partnerships with the Health and Care System 
        • Joint Working 
        • Collaborative Working 
          • The Newcastle upon Tyne Hospitals NHS Foundation Trust 
        • External Funding 
        • Patient Group Partnership 
      • Sponsorships 
      • Diseases 
      • Strategy 
      • People and Culture 
      • Who We Are 
      01077_144dpi_16by9_PPT_RGB About
    • Patients and Caregivers 
      • External Funding 
      • Patient Group Partnership 
      • Health Coaching Video Series 
      Doctor and Patient Patients and Caregivers
    • Healthcare Professionals 
      • For UK Healthcare Professionals 
      Healthcare Professional Writing Healthcare Professionals
    • ESG 
      • Ethical Behaviour 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      • Transparency 
        • Healthcare Professional Payment Transparency 
      • Health Inequalities 
      Young girl in doctor's office ESG
    • News 
      • Stories 
      • News Archive 
      • Novartis UK Press Office 
      Professional Colleagues Working Together News
    • Careers 
      • Career Search 
      • Personal Growth 
      • Early Talent 
      • How We Work 
      • Well-being 
      • Career Programmes 
        • Future Talent Programme 
      • Awards and Recognition 
      Novartis building Careers
    • Coronavirus 
    • Contact 
    Home Home
Header
Biologists Collaborating

Novartis UK

At Novartis, we are reimagining medicine

Previous Next
Two scientists performing chemical analysis

Novartis Financial Results – Q3 2022

Novartis announced the company's financial results for the third quarter of 2022

Read More
White City Office

Novartis in the UK

We invite you to learn more about Novartis and our impact on patients, families and their communities.

Learn More
Two people holding hands

Patient Group Partnership

At Novartis, we’re united by a shared purpose of putting patients at the heart of everything we do and being a bold partner for progress to the patient community.

Learn More
Children Jumping

About Novartis

We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.

Doctor and Patient

Patients and Caregivers

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives.

Healthcare Professional Writing

Healthcare Professionals

Novartis works closely with healthcare professionals around the work to support their treatment of patients and collaborate on unmet needs.

colleagues in office people and culture_0

People and Culture

Novartis is building an inspired, curious and unbossed culture.

Novartis building

Careers

769 million lives touched by our products. Join us.

Young girl in doctor's office

ESG

We are committed to creating a culture of integrity.

Novartis UK

Navigate Novartis
  • Patients and Caregivers
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
  • Coronavirus
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Information
Other Novartis Websites
  • Healthcare Professional Portal
  • Sandoz UK
  • Novartis Global
  • Advanced Accelerator Applications
  • Novartis Biome
  • Novartis Clinical Trials
Footer Bottom
© 2023 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Contact
  • Web Accessibility
  • Modern Slavery Statement
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for an audience in the UK